Opcon-A is a brand name of Naphazoline and pheniramine, an over-the-counter medicine. The FDA NDC Directory lists 2 Opcon-A products in 1 strength and form.

Bausch and Lomb holds the FDA application for Opcon-A (NDA020065, approved June 8, 1994).

Is there a generic or store brand of Opcon-A?

Yes. The FDA NDC Directory lists 5 other products with the same active ingredients, strength and form as a Opcon-A product. Ask your pharmacist whether one is right for you.

Opcon-A (Naphazoline and pheniramine): maker, FDA approval and generic versions

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Read the label on your package, and ask a pharmacist if you are not sure a medicine is right for you or your child.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Opcon-A?: Opcon-A is a brand name of Naphazoline and pheniramine, an over-the-counter medicine. The FDA NDC Directory lists 2 Opcon-A products in 1 strength and form.
Who makes Opcon-A?: Bausch and Lomb holds the FDA application for Opcon-A (NDA020065, approved June 8, 1994).
Is there a generic or store brand of Opcon-A?: Yes. The FDA NDC Directory lists 5 other products with the same active ingredients, strength and form as a Opcon-A product. Ask your pharmacist whether one is right for you.
Has Opcon-A been recalled?: No recall linked to Opcon-A products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Opcon-A is

Each Opcon-A product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Naphazoline and pheniramine · over-the-counter medicine

Strength and form	Product names	Same medicine, other names	Label
naphazoline hydrochloride 0.2675 mg/mL · pheniramine maleate 3.15 mg/mL solution/ drops (ophthalmic)	Opcon-A	5 products, 5 companies	DailyMed

Its page quotes the Drug Facts label and lists every brand and store brand: Naphazoline and pheniramine →

FDA approval

NDA: New Drug Application: how a new (usually brand-name) medicine is approved.

FDA applications of Opcon-A products (Drugs@FDA)
Application	Holder	First approved	Products
NDA020065	Bausch and Lomb	June 8, 1994	2

Companies that list Opcon-A

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Opcon-A products.

Bausch & Lomb Incorporated2 products

Recalls

No recall linked to Opcon-A products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers

Opcon-A